Journal article
Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development
DG Hill, L Yu, H Gao, JJ Balic, A West, H Oshima, L McLeod, M Oshima, A Gallimore, K D'Costa, PS Bhathal, W Sievert, RL Ferrero, BJ Jenkins, GW Jones
International Journal of Cancer | WILEY | Published : 2018
DOI: 10.1002/ijc.31298
Open access
Abstract
Tertiary lymphoid structures (TLSs) display phenotypic and functional characteristics of secondary lymphoid organs, and often develop in tissues affected by chronic inflammation, as well as in certain inflammation-associated cancers where they are prognostic of improved patient survival. However, the mechanisms that govern the development of tumour-associated TLSs remain ill-defined. Here, we observed tumour-associated TLSs in a preclinical mouse model (gp130F/F) of gastric cancer, where tumourigenesis is dependent on hyperactive STAT3 signalling through the common IL-6 family signalling receptor, gp130. Gastric tumourigenesis was associated with the development of B and T cell-rich submucos..
View full abstractGrants
Awarded by Medical Research Council
Funding Acknowledgements
Grant sponsor: Arthritis Research UK; Grant number: 20305; Grant sponsor: Medical Research Council; Grant sponsor: The Wellcome Trust ISSF; Grant sponsor: Cancer Research UK Cardiff Centre; Grant sponsor: Victorian Government's Operational Infrastructure Support Program; Grant sponsor: National Health and Medical Research Council of Australia (NHMRC); Grant sponsor: NHMRC Senior Research Fellowships; Grant sponsor: Australian Government Australian Postgraduate Award; Grant sponsor: Life Sciences Research Network Wales; Grant sponsor: International Postgraduate Scholarship (Monash University)